A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to α2,8-disialyl and branched α2,6-sialyl residues -: A comparison with Siglec-9

被引:166
作者
Yamaji, T [1 ]
Teranishi, T [1 ]
Alphey, MS [1 ]
Crocker, PR [1 ]
Hashimoto, Y [1 ]
机构
[1] Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland
关键词
D O I
10.1074/jbc.M110146200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Siglec-7 is a sialic acid-binding lectin recently identified as an inhibitory receptor on natural killer cells. Here we characterize the sugar-binding specificity of Siglec-7 expressed on Chinese hamster ovary cells using polyvalent streptavidin-based glyco-probes. Glycoprobes carrying unique oligosaccharide structures such as GD3 (NeuAcalpha2,8NeuAcalpha2,3Galbeta1,4Glc) and LSTb (Galbeta1,3[NeuAcalpha2,6]GlcNAcbeta1,3Galbeta1,4Glc) oligosaccharides bound to Siglec-7 better than those carrying LSTc (NeuAcalpha2,6Galbeta1,4GlcNAcbeta1,3Galbeta1,4Glc) or GD1a (NeuAcalpha2,3 Galbeta1,3GalNAcbeta1,4[NeuAcalpha2,3]Gal-beta1,4Glc) oligosaccharides. In contrast, Siglee-9, which is 84% identical to Siglec-7, did not bind to the GD3 and LSTb probes but did bind to the LSTc and GD1a probes. To identify a region(s) responsible for their difference in binding specificity, we prepared a series of V-set domain chimeras between Siglecs-7 and -9. Substitution of a small region, Asn(70)-Lys(75), of Siglec-7 with the equivalent region of Siglec-9 resulted in loss of Siglec-7-like binding specificity and acquisition of Siglec-9-like binding properties. In comparison, a Siglec-9-based chimera, which contains Asn(70)-Lys(75) with additional amino acids derived from Siglec-7, exhibited Siglec-7-like specificity. These results, combined with molecular modeling, suggest that the C-C' loop in the sugar-binding domain plays a major role in determining the binding specificities of Siglecs-7 and -9.
引用
收藏
页码:6324 / 6332
页数:9
相关论文
共 33 条
[1]   Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily [J].
Angata, T ;
Varki, A .
GLYCOBIOLOGY, 2000, 10 (04) :431-438
[2]   New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope [J].
Brinkman-Van der Linden, ECM ;
Varki, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8625-8632
[3]   Structural analysis of trisialylated biantennary glycans isolated from mouse serum transferrin -: Characterization of the sequence Neu5Gc(α2-3)Gal(β1-3)[Neu5Gc(α2-6)]GlcNAc(β1-2)Man [J].
Coddeville, B ;
Regoeczi, E ;
Strecker, G ;
Plancke, Y ;
Spik, G .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2000, 1475 (03) :321-328
[4]   Binding specificities of the sialoadhesin family of I-type lectins - Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin [J].
Collins, BE ;
Kiso, M ;
Hasegawa, A ;
Tropak, MB ;
Roder, JC ;
Crocker, PR ;
Schnaar, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :16889-16895
[5]   A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells [J].
Colonna, M ;
Nakajima, H ;
Navarro, F ;
López-Botet, M .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (03) :375-381
[6]  
Crocker P R, 1998, Glycobiology, V8, pv
[7]   PURIFICATION AND PROPERTIES OF SIALOADHESIN, A SIALIC ACID-BINDING RECEPTOR OF MURINE TISSUE MACROPHAGES [J].
CROCKER, PR ;
KELM, S ;
DUBOIS, C ;
MARTIN, B ;
MCWILLIAM, AS ;
SHOTTON, DM ;
PAULSON, JC ;
GORDON, S .
EMBO JOURNAL, 1991, 10 (07) :1661-1669
[8]   Siglecs, sialic acids and innate immunity [J].
Crocker, PR ;
Varki, A .
TRENDS IN IMMUNOLOGY, 2001, 22 (06) :337-342
[9]   Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells [J].
Falco, M ;
Biassoni, R ;
Bottino, C ;
Vitale, M ;
Sivori, S ;
Augugliaro, R ;
Moretta, L ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) :793-801
[10]   A novel subset of murine B cells that expresses unmasked forms of CD22 is enriched in the bone marrow: implications for B-cell homing to the bone marrow [J].
Floyd, H ;
Nitschke, L ;
Crocker, PR .
IMMUNOLOGY, 2000, 101 (03) :342-347